Phenelzine is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
No data available for utilization in pregnant women
Breastfeeding warnings:
Drug distribution in breast milk is unknown, so use the drug cautiously during lactation.
Pregnancy category:
- Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
- Category B: No evidence shows the risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women.
- Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a product in humans; Pregnant women must take care of the potential risks.
- Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms. However, despite potential dangers may be used only in emergency cases for potential benefits.
- Category X: Drugs listed in this category outweigh the risks over the benefits. The drug is not for pregnant women.
- Category N: No data is available for the drug under this category.
Patient information leaflet
Generic Name: phenelzine
Pronounced: phen-el-zine
Why do we use phenelzine?
Phenelzine lies under MAO inhibitors and treats depression.
